Search
for

    Learn

    5 / 801 results

      learn Cyproterone

      a synthetic anti-androgen and weak progestogen that inhibits DHT binding to androgen receptor

      learn Fluridil

      a topical anti-androgen with less systemic involvement

      learn RU58841

      a potent but unapproved and potentially problematic topical anti-androgen

      learn Pyrilutamide

      highly targeted anti-androgen that might have minimal systemic effects

    Research

    5 / 1000+ results

    Community Join

    5 / 1000+ results

      community AA and Hirsutism but T levels are normal

      in Female  6 upvotes 5 years ago
      27-year-old female experiences aggressive hair thinning and hirsutism despite normal testosterone levels. Spironolactone and 2% minoxidil were ineffective; high DHEA sulfate levels may be the cause.

      community Spironolactine Update: 2 months (34, Female)

      in Female  22 upvotes 9 years ago
      A female user's experience using Spironolactone to treat Female Pattern Hair Loss (FPHL) and Androgenic Alopecia, as well as discussing the effectiveness of the drug at different dosages.

      community The Hormonal Profile of MPB/AGA

      in Research/Science  9 upvotes 4 years ago
      Men with early male pattern baldness (MPB) may have hormonal abnormalities similar to those in women with PCOS. Specific treatments mentioned include Minoxidil, Finasteride, and RU58841.

      community Just got some test results back.

      in Finasteride/Dutasteride  5 upvotes 5 years ago
      The user received hormone test results showing normal estradiol and testosterone levels, low SHBG, and normal free androgen index. They are considering starting finasteride but are concerned due to being slightly overweight.

      community HMI 115 Phase 2 - Leaked pics from Discord

      in Research/Science  362 upvotes 1 year ago
      The conversation discusses HMI 115, a new hair loss treatment with promising results, showing a significant increase in hair density after two months. Some users are skeptical, while others are hopeful for its release and potential affordability.